HIV 1 News and Research

RSS

Irish Government launches program to provide life insurance to people with HIV, Hep C through contaminated blood products

The Irish government on Thursday launched a program to provide life insurance, mortgage protection and travel insurance to people who contracted HIV or hepatitis C through contaminated blood products, Ireland's Evening Echo reports (Evening Echo, 9/27).

2 Oct 2007

Judge acquits Canadian doctors, U.S. drug company in tainted blood case

A Canadian judge on Monday acquitted New Jersey-based Armour Pharmaceutical Company and four Canadian doctors -- including the former medical director of the Canadian Red Cross and two government officials -- of charges related to blood products contaminated with HIV and hepatitis C, the New York Times reports (Austen, New York Times, 10/2).

2 Oct 2007

Washington, D.C., community groups return 70,000 condoms given away in program to reduce STIs

Community groups in Washington, D.C., last week returned up to 70,000 of the condoms given away earlier this year as part of a city program that aims to reduce the spread of HIV and other sexually transmitted infections, the AP/Google.com reports.

2 Oct 2007

Officials say, although China has low HIV prevalence, situation serious in some provinces affected by drug trafficking, illegal blood donations

While the HIV prevalence in China remains low, the situation in several provinces affected by drug trafficking and illegal blood donations is serious, senior HIV/AIDS control officials said on Saturday, Xinhua/China Daily reports.

2 Oct 2007

NIH awards Atlanta-based firm $15M for HIV vaccine research

NIH has awarded the Atlanta-based firm GeoVax Labs a $15 million grant to further its HIV vaccine research and continue human clinical trials, company officials announced Thursday, the Atlanta Journal-Constitution reports.

2 Oct 2007

Prisons in Maryland have highest percentage of AIDS cases nationwide

Prisons in Maryland have the highest percentage of inmates living with AIDS nationwide, according to a study by the Department of Justice, the Baltimore Sun reports. The study is based on statistics from 41 states at the end of 2005.

2 Oct 2007

New way to fight hepatitis B

One in four people who are chronically infected with hepatitis B will die from its impact if untreated, but a team of researchers at the Stanford University School of Medicine has identified the most cost-effective way of fighting this treacherous infection.

2 Oct 2007

Second pathway behind HIV-associated immune system dysfunction identified

Researchers at the Partners AIDS Research Center at Massachusetts General Hospital (PARC-MGH) may have discovered a second molecular "switch" responsible for turning off the immune system's response against HIV.

1 Oct 2007

microRNAs may be key to HIV's ability to hide, evade drugs

Tiny pieces of genetic material called microRNA (miRNA), better known for its roles in cancer, could be a key to unlocking the secrets of how HIV, the AIDS virus, evades detection, hiding in the immune system.

1 Oct 2007

Majority of Europeans with hepatitis C remain undiagnosed

A report by the Eurasian Harm Reduction Network (EHRN highlights the significant inconsistencies that exist in hepatitis C (HCV) diagnosis and treatment across Europe and beyond. In recognition of World Hepatitis Awareness Day, patient groups around the globe are united in their call for action.

1 Oct 2007

Simple tool improves communication between doctors and patients

A UCSF research team has developed a simple tool that can improve the effectiveness of communication between doctors and patients about prescribed medications and result in dramatic improvements in health and safety.

29 Sep 2007

DNA damage response confers a barrier for viral tumorigenesis

Kaposi's sarcoma herpesvirus (KSHV) is a human tumor virus and an etiological agent for Kaposi's sarcoma (KS).

27 Sep 2007

CDC awards $35 million to increase HIV testing opportunities

The Centers for Disease Control and Prevention has awarded $35 million in funding to state and local health departments to increase HIV testing opportunities among populations disproportionately affected by HIV, primarily African Americans.

27 Sep 2007

WHO essential emergency training to save lives and prevent disability

WHO is expanding its programme to train health care staff in low- and middle-income countries in essential emergency, basic surgery and anaesthesia skills.

25 Sep 2007

WHO and its partners call for increased research to improve patient safety

They emphasized the need for intensified research at an international conference that opened today in Porto, Portugal. The conference on Patient safety research: shaping the European agenda will examine evidence showing that harm from medical care poses a substantial burden in terms of suffering and death in Europe and around the world.

25 Sep 2007

New Pfizer HIV drug approved for sale in Europe

Drug giant Pfizer has been given approval for it's new HIV drug Celsentri to go on sale in Europe.

24 Sep 2007

Trials of a new HIV vaccine come to an abrupt halt

Trials of a new HIV vaccine have come to an abrupt halt after it did not prevent volunteers from becoming infected.

24 Sep 2007

Promoting safety of medicines for children

The lack of thorough and reliable clinical data on the way medicines affect children requires strengthened safety monitoring and vigilance of medicinal products.

24 Sep 2007

Acute loss of intestinal CD4+ T cells is not predictive of SIV virulence

A sudden loss of T cells -- white blood cells crucial to the immune system -- is not the trigger for the onset of AIDS, according to a study published in the September 2007 issue of the Journal of Immunology by a team of researchers at Tulane National Primate Research Center.

24 Sep 2007

Study highlights shared burden of young carers in the UK and Tanzania

It's not just distance that separates the children of Tanzania and the UK. Their lifestyles, aspirations and access to employment, education and healthcare are worlds apart.

24 Sep 2007